Beiersdorf first half
This article was originally published in The Rose Sheet
Executive Summary
Strong Nivea sales led Beiersdorf's Cosmed division to 6.1% sales increase to $1.61 bil. (€1=$.98) in the six months ended June 30, German company announces during in 1an Aug. 13 release. Nivea For Men skin care generated 20.6% higher in sales, while Nivea deodorant grew 14.6% on a global basis, firm notes. Cosmed earnings before interest and taxes rose slightly to $226 mil. Division sales in the Americas fell 10.6% due to economic instability in Argentina, Brazil and Mexico and the weaker U.S. dollar, company notes. Beiersdorf's consolidated sales for the first six months of the year increased 3.3% to $2.41 bil., and earnings before interest and taxes increased 3.3% to $254.3 mil., excluding income from the sale of firm's advanced wound care business...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.